These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 21384412)
1. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease. Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412 [TBL] [Abstract][Full Text] [Related]
2. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity. Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865 [TBL] [Abstract][Full Text] [Related]
3. NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer's disease, in response to a new lipophilic molecular combination codrug-1. Zara S; Di Stefano A; Nasuti C; Rapino M; Patruno A; Pesce M; Sozio P; Cerasa LS; Cataldi A Exp Gerontol; 2011 Apr; 46(4):273-81. PubMed ID: 21070848 [TBL] [Abstract][Full Text] [Related]
4. Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model. Di Stefano A; Sozio P; Cerasa LS; Iannitelli A; Cataldi A; Zara S; Giorgioni G; Nasuti C Int J Immunopathol Pharmacol; 2010; 23(2):589-99. PubMed ID: 20646354 [TBL] [Abstract][Full Text] [Related]
5. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model. Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649 [TBL] [Abstract][Full Text] [Related]
6. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats. Kumar A; Seghal N; Padi SV; Naidu PS Eur J Pharmacol; 2006 Dec; 551(1-3):58-66. PubMed ID: 17027965 [TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response. Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489 [TBL] [Abstract][Full Text] [Related]
10. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice. Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317 [TBL] [Abstract][Full Text] [Related]
11. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958 [TBL] [Abstract][Full Text] [Related]
12. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism. Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917 [TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Abdul HM; Calabrese V; Calvani M; Butterfield DA J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. Sharma S; Verma S; Kapoor M; Saini A; Nehru B Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920 [TBL] [Abstract][Full Text] [Related]
15. Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model. Van Dam D; Coen K; De Deyn PP J Psychopharmacol; 2010 Mar; 24(3):383-8. PubMed ID: 18957478 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Kim CY; Lee C; Park GH; Jang JH Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365 [TBL] [Abstract][Full Text] [Related]
17. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Jiménez-Aliaga K; Bermejo-Bescós P; Benedí J; Martín-Aragón S Life Sci; 2011 Dec; 89(25-26):939-45. PubMed ID: 22008478 [TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Boyd-Kimball D; Sultana R; Abdul HM; Butterfield DA J Neurosci Res; 2005 Mar; 79(5):700-6. PubMed ID: 15678514 [TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons. Liu T; Jin H; Sun QR; Xu JH; Hu HT Neuropharmacology; 2010 Dec; 59(7-8):595-604. PubMed ID: 20800073 [TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. Gasparini L; Ongini E; Wenk G J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]